Prescription drug · ANDA
Pantoprazole Sodium (pantoprazole) NDC 85509-1636
Pantoprazole sodium 20 mg/1 · Tablet, Delayed release · Oral · PHOENIX RX LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 85509-1636-3 | 85509163603 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (85509-1636-3)Marketed from Nov 20, 2025 | |
| 85509-1636-6 | 85509163606 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (85509-1636-6)Marketed from Nov 20, 2025 | |
| 85509-1636-9 | 85509163609 | 90 TABLET, DELAYED RELEASE in 1 BOTTLE (85509-1636-9)Marketed from Nov 20, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Pantoprazole Sodium
- Generic name (nonproprietary)
- pantoprazole
- Active ingredients
- Pantoprazole sodium — 20 mg/1
- Dosage form
- Tablet, Delayed release
- Route
- Oral
- Labeler
- PHOENIX RX LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 205119
- Marketing start
- Listing expires
- Other FDA classes
- Proton Pump Inhibitors (Mechanism)
- Identifiers
- Product ID 85509-1636_440b9278-eab8-6434-e063-6394a90ac398SPL ID 440b9278-eab8-6434-e063-6394a90ac398SPL set ID 440b9ae8-2fb8-5d35-e063-6294a90a82b6RxCUI 251872UNII 6871619Q5X
- Pharmacologic class
- Proton Pump Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N485509163603followed by a unit qualifier and the quantityPackage 85509-1636-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Pantoprazole sodium delayed-release tablets are indicated for: Pantoprazole sodium is a proton pump inhibitor (PPI) indicated for the following: Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD). ( 1.1 ) Maintenance of Healing of Erosive Esophagitis. ( 1.2 ) Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome. ( 1.3 ) 1.1 Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD) Pantoprazole sodium delayed-release tablets are indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic reli…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 205119
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Pantoprazole Sodiumpantoprazole | Pantoprazole sodium 20 mg/1 | Tablet, Delayed releaseOral | Amneal Pharmaceuticals LLC | 65162-636 |
| Pantoprazole Sodiumpantoprazole | Pantoprazole sodium 40 mg/1 | Tablet, Delayed releaseOral | Amneal Pharmaceuticals LLC | 65162-637 |
| Pantoprazole Sodiumpantoprazole | Pantoprazole sodium 20 mg/1 | Tablet, Delayed releaseOral | Proficient Rx LP | 63187-837 |
| Pantoprazole Sodium DRpantoprazole sodium | Pantoprazole sodium 20 mg/1 | Tablet, Delayed releaseOral | Advanced Rx of Tennessee, LLC | 80425-0085 |
| Pantoprazole Sodiumpantoprazole | Pantoprazole sodium 20 mg/1 | Tablet, Delayed releaseOral | Bryant Ranch Prepack | 71335-0291 |
| Pantoprazole Sodiumpantoprazole | Pantoprazole sodium 40 mg/1 | Tablet, Delayed releaseOral | Proficient Rx LP | 63187-974 |